Gentian Diagnostics ASA (OSL:GENT)
Norway
· Delayed Price · Currency is NOK 39.00
-0.50 (-1.27%)
At close: Mar 6, 2026
Gentian Diagnostics ASA Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 176.5 | 152.07 | 135.15 | 101.64 | 83.12 | Upgrade
|
| Other Revenue | - | - | - | 10.29 | 16.89 | Upgrade
|
| Revenue | 176.5 | 152.07 | 135.15 | 111.92 | 100.01 | Upgrade
|
| Revenue Growth (YoY) | 16.06% | 12.52% | 20.76% | 11.91% | 26.78% | Upgrade
|
| Cost of Revenue | 78.3 | 69.25 | 70.91 | 52.64 | 43.18 | Upgrade
|
| Gross Profit | 98.2 | 82.82 | 64.25 | 59.29 | 56.83 | Upgrade
|
| Selling, General & Admin | 54.33 | 49.78 | 48.12 | 37.42 | 34.35 | Upgrade
|
| Research & Development | 23.16 | 21.92 | 36.08 | - | - | Upgrade
|
| Other Operating Expenses | -4.75 | -4.6 | -7.19 | 34.86 | 37.98 | Upgrade
|
| Operating Expenses | 72.75 | 67.09 | 77.01 | 82.52 | 79.68 | Upgrade
|
| Operating Income | 25.45 | 15.72 | -12.76 | -23.23 | -22.85 | Upgrade
|
| Interest Expense | -5.22 | -0.66 | -0.8 | -1.26 | -1.38 | Upgrade
|
| Interest & Investment Income | 5.43 | 3.59 | 2.67 | 1.11 | 0.09 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 1.5 | 0.6 | -0.2 | -0.6 | Upgrade
|
| Other Non Operating Income (Expenses) | - | -0.08 | -0.08 | -0.05 | -0.06 | Upgrade
|
| EBT Excluding Unusual Items | 25.67 | 20.06 | -10.37 | -23.62 | -24.79 | Upgrade
|
| Pretax Income | 25.67 | 20.06 | -10.37 | -23.62 | -24.79 | Upgrade
|
| Income Tax Expense | 12.41 | -25.23 | 0.28 | - | - | Upgrade
|
| Net Income | 13.26 | 45.29 | -10.65 | -23.62 | -24.79 | Upgrade
|
| Net Income to Common | 13.26 | 45.29 | -10.65 | -23.62 | -24.79 | Upgrade
|
| Net Income Growth | -70.73% | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 15 | 15 | 15 | 15 | 15 | Upgrade
|
| Shares Outstanding (Diluted) | 15 | 16 | 15 | 15 | 15 | Upgrade
|
| Shares Change (YoY) | -1.73% | 2.21% | - | 0.04% | 0.07% | Upgrade
|
| EPS (Basic) | 0.86 | 2.94 | -0.69 | -1.53 | -1.61 | Upgrade
|
| EPS (Diluted) | 0.86 | 2.87 | -0.69 | -1.53 | -1.61 | Upgrade
|
| EPS Growth | -70.05% | - | - | - | - | Upgrade
|
| Free Cash Flow | 41.38 | 12.08 | 14.5 | -22.59 | -28.08 | Upgrade
|
| Free Cash Flow Per Share | 2.67 | 0.77 | 0.94 | -1.47 | -1.82 | Upgrade
|
| Dividend Per Share | 0.600 | 0.400 | - | - | - | Upgrade
|
| Dividend Growth | 50.00% | - | - | - | - | Upgrade
|
| Gross Margin | 55.64% | 54.46% | 47.54% | 52.97% | 56.83% | Upgrade
|
| Operating Margin | 14.42% | 10.34% | -9.44% | -20.76% | -22.84% | Upgrade
|
| Profit Margin | 7.51% | 29.79% | -7.88% | -21.10% | -24.79% | Upgrade
|
| Free Cash Flow Margin | 23.45% | 7.94% | 10.73% | -20.18% | -28.07% | Upgrade
|
| EBITDA | 34.57 | 18.6 | -9.9 | -20.49 | -21.32 | Upgrade
|
| EBITDA Margin | 19.58% | 12.23% | -7.32% | -18.30% | -21.32% | Upgrade
|
| D&A For EBITDA | 9.12 | 2.88 | 2.87 | 2.75 | 1.53 | Upgrade
|
| EBIT | 25.45 | 15.72 | -12.76 | -23.23 | -22.85 | Upgrade
|
| EBIT Margin | 14.42% | 10.34% | -9.44% | -20.76% | -22.84% | Upgrade
|
| Effective Tax Rate | 48.35% | - | - | - | - | Upgrade
|
| Revenue as Reported | - | - | - | 111.92 | 100.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.